Trial Profile
Phase I Trial to Compare Pharmacokinetics and Safety of Docetaxel PNP With Taxotere in Subjects With Advanced Solid Tumor
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 May 2017
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Samyang Biopharmaceuticals Corporation
- 27 Apr 2017 Status changed from not yet recruiting to completed.
- 28 Oct 2014 New trial record